Literature DB >> 17900306

Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases.

M Borro1, G Gentile, A Stigliano, S Misiti, V Toscano, M Simmaco.   

Abstract

T lymphocytes and/or their subpopulations from peripheral blood may represent molecular sensors to be used for the evaluation of gene expression modification in physiological and pathological conditions, providing a unique and easily available biological model for integrated studies of gene expression in humans. In this study, a proteomic approach was applied to evaluate the association between changes in T cell protein expression patterns and specific diseased conditions. In particular, two hyperandrogenic syndromes were studied, sharing many clinical and biochemical signs: polycystic ovary syndrome (PCOS) and congenital adrenal hyperplasia (CAH). Comparison of proteomic maps of T lymphocytes derived from patients affected by PCOS or CAH with those derived from healthy subjects showed that 14 proteins are expressed differentially in both PCOS and CAH, 15 exclusively in PCOS and 35 exclusively in CAH. Seventeen of these proteins have been identified by mass spectrometry analysis. Furthermore, proteomic data mining by hierarchical clustering was performed, highlighting T lymphocytes competence as a living biosensor system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900306      PMCID: PMC2219372          DOI: 10.1111/j.1365-2249.2007.03498.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  Machinery of protein folding and unfolding.

Authors:  Xiaodong Zhang; Fabienne Beuron; Paul S Freemont
Journal:  Curr Opin Struct Biol       Date:  2002-04       Impact factor: 6.809

Review 2.  Multifunctional alpha-enolase: its role in diseases.

Authors:  V Pancholi
Journal:  Cell Mol Life Sci       Date:  2001-06       Impact factor: 9.261

Review 3.  Newborn screening for congenital adrenal hyperplasia.

Authors:  B L Therrell
Journal:  Endocrinol Metab Clin North Am       Date:  2001-03       Impact factor: 4.741

Review 4.  Cytoskeletal remodeling in lymphocyte activation.

Authors:  Ana V Miletic; Maciej Swat; Keiko Fujikawa; Wojciech Swat
Journal:  Curr Opin Immunol       Date:  2003-06       Impact factor: 7.486

5.  The crystal structure of CCG1/TAF(II)250-interacting factor B (CIB).

Authors:  Balasundaram Padmanabhan; Takashi Kuzuhara; Naruhiko Adachi; Masami Horikoshi
Journal:  J Biol Chem       Date:  2003-12-11       Impact factor: 5.157

Review 6.  The pathophysiology of polycystic ovary syndrome.

Authors:  Tasoula Tsilchorozidou; Caroline Overton; Gerard S Conway
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

7.  Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression background.

Authors:  Marc Weinkauf; Wolfgang Hiddemann; Martin Dreyling
Journal:  Electrophoresis       Date:  2006-11       Impact factor: 3.535

Review 8.  Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?

Authors:  F Boehlen; K J Clemetson
Journal:  Transfus Med       Date:  2001-12       Impact factor: 2.019

9.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Regulation of sulfated glycoprotein-1 and cathepsin D expression in adult rat epididymis.

Authors:  Louis Hermo; Sero Andonian
Journal:  J Androl       Date:  2003 May-Jun
View more
  2 in total

Review 1.  Application of proteomics to the study of polycystic ovary syndrome.

Authors:  M Insenser; H F Escobar-Morreale
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 4.256

2.  Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome.

Authors:  Michelle R Jones; Angela Chua; Yii-Der I Chen; Xiaohui Li; Ronald M Krauss; Jerome I Rotter; Richard S Legro; Ricardo Azziz; Mark O Goodarzi
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.